Artwork

Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Test helps identify elusive central nervous system pathogens: Robin Patel, M.D.

7:10
 
Share
 

Manage episode 393012418 series 2908385
Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Robin Patel, M.D., explains how a new Mayo Clinic Laboratories' assay can identify central nervous system pathogens that standard tests fail to detect. Rapid, precise diagnosis is essential to preventing long-term effects from these infections.

Show notes

Speaker 3: (00:32)
Please give us a brief introduction of yourself and your role at Mayo Clinic.

Speaker 3: (01:44)
Could you please expand a bit on this newly developed sequencing assay — which is a shotgun metagenomic test on CSF — and explain how it's different from other sequencing methods?

Speaker 3: (02:43)
Could you tell us more about the specific group of patients this test would be used for and how a provider might identify those patients? When during the care process should this be ordered?

Speaker 3: (04:12)
Could you talk about the alternative test options and how they compare?

Speaker 3: (05:42)
How are the results used in patient care?

  continue reading

308 episodes

Artwork
iconShare
 
Manage episode 393012418 series 2908385
Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Robin Patel, M.D., explains how a new Mayo Clinic Laboratories' assay can identify central nervous system pathogens that standard tests fail to detect. Rapid, precise diagnosis is essential to preventing long-term effects from these infections.

Show notes

Speaker 3: (00:32)
Please give us a brief introduction of yourself and your role at Mayo Clinic.

Speaker 3: (01:44)
Could you please expand a bit on this newly developed sequencing assay — which is a shotgun metagenomic test on CSF — and explain how it's different from other sequencing methods?

Speaker 3: (02:43)
Could you tell us more about the specific group of patients this test would be used for and how a provider might identify those patients? When during the care process should this be ordered?

Speaker 3: (04:12)
Could you talk about the alternative test options and how they compare?

Speaker 3: (05:42)
How are the results used in patient care?

  continue reading

308 episodes

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide